Our Patient’s Journey


Home & Wellness

This section of the patient’s journey includes wellness devices as well as user-friendly early detection medical devices that healthy individuals can use to maintain their general well-being at home.

sensetime (CIH)

Facial recognition temperature sensor
registration system

Virtu-Flavour (CIH)

Flavour augmenting utensils through the digitalisation of senses

vkmcs-v2-1 (CIH)

Photocatalyst Air Sterilization

Puradigm-v2 (CIH)

Inactivation of Bacteria and Virus
by Puradigm® Technology


Primary Care & Early Detection

 This section of the patient’s journey includes simple and compact devices that general physicians can use to give a quick diagnosis of various conditions, as well as telemonitoring devices that allows physicians to communicate with the patient at home or in certain cases for physicians to get advice from other specialists. It enables the patient’s primary physician to detect various conditions early, before triaging patients with clinically significant conditions to the hospital for necessary intervention.

bio-rithm-logo (CIH)

Remote fetal & maternal heart rate monitoring using ECG/EMG technology

pulsered (CIH)

Photoplethysmographic quantitative
Buerger’s Test

kronikare (CIH)

AI wound
management tool

beluntech-logo (CIH)

Monitoring of risk of sleep apena and sleep quality through vital signs ring

Ai-Sound (CIH)

Smartsensor for distinguishing normal
and abnormal lung sounds


A microRNA blood test for early detection
of gastric cancer


Integrated Hospital Care & Smart Ward

 This section of the patient’s journey encompasses a collection of innovations that are used to treat the complex acute conditions that patients present with at the hospital. These include the latest AI technologies used to monitor various parameters and vital signs, and may contribute towards the future set up of the smart ward in Alexandra Hospital, helping to increase efficiency in the workflow of healthcare workers.

WiSe (CIH)

Wireless monitoring of post-surgical complications at suture site

PaperBreath (CIH)

Point of care detection of
diabetic ketoacidosis


Fabric-based Exosuit to Help Nurses
with Lifting Patients

Hillrom_Logo_TM_CMYK_Hor_Pos-v2-1 (CIH)


hicuramedical (CIH)

Ultrasound guided AI based
anaesthesiology procedures

TEMI-v2-1 (CIH)

The Personal Robot

DOOG-v2-1 (CIH)

Robotic Wheelchair

lionsbot (CIH)

UV disinfection robot

pbarobotics (CIH)

UV disinfection robot

Invivo-v2 (CIH)

Assistive Device for Safe and
Precision Percutaneous Access

endofotonics (CIH)

AI based real time diagnosis
of gastrointestinal cancer

endomastermedical (CIH)

Facial recognition temperature sensor
registration system

EndoPil-logo (CIH)

Self inflating magnetic pouch for weight management

atdose (CIH)

Mobile-type dosing device


Novel Handheld Robotic Ventilation Tube Applicator For Glue Ear


AI Assistant that analyses digital mammograms to assist in early detection of breast cancer


A spacer paired with a mobile app to improve asthma medication delivery and compliance

Cell Therapy of Leukemia

A new treatment for leukemia and lymphoma based on harnessing patient’s own immune cells and directing them to specific targets on cancer cells that will be more effective and yet, less toxic


Community Care & Rehabilitation

 This last category of the patient’s journey includes innovations which allow for patients to continue to receive specialised care at the comfort of their homes or in less acute facilities. By providing patients with the necessary technology to manage their own care, it not only reduces the burden on hospitals, but also empowers the patient.

willandwell (CIH)

Inclusive functional clothing

roceso (CIH)

Rehabilitation soft robotic EsoGlove

quantumtx (CIH)

Magnetic field activation
of mitochondrial muscles

Kenn (CIH)

Redesigned hand splint for elderly
with spinal chord injury

Skinfinity-v2 (CIH)

Tongue Pressure Mapping Device

HUR-v2 (CIH)

Perfect Tool for Assessing
and Training Balance

What Our Innovators Say About Us

Gui Chuanhao

House Officer, Tan Tock Seng Hospital
MBBS Graduate of NUS Yong Loo Lin School of Medicine
1st Prize, Team Paper Breath, Medical Grand Challenge 2018
Founder, Breath Technologies

CIH has been nothing but helpful in my journey to bring my innovation into the market. Despite being just a medical student, I got the chance to meet so many people from the industries who are able to advise me on how to navigate the medtech space. Through these guidance and partnerships, I have gained new insights on how to better develop my product to suit the market. I look forward to a strong partnership with CIH in the coming years!

Joseph Zhao

Medical Student, NUS Yong Loo Lin School of Medicine
Special Mention Award, Team PulseRed (Medical Grand Challenge 2019)
3rd Prize, Team SlideEasy (Medical Grand Challenge 2018)

I got to know the CIH team when I was just a student hoping to solve some medical problems. Even though I was very new to medical innovation, CIH patiently guided me through the starting processes of product development, working with regulations and designing studies.

The time I spent at CIH has been enriching and fulfilling in many ways. I have learnt so much from the experience working with them, and gained even greater inspirations from their enthusiasm. The team’s vision for the future of medical innovation and their resilience in pursuing it has meaningfully shaped my own insights and dreams about the field.

CIH has been an integral and memorable part of my journey since stepping into medical innovation. I look forward to seeing more great things coming from them in the years to come.

Viveka K.

Postdoc Research Fellow, National University of Singapore
Team WISE Sutures, Winner of LOTUS-NUS Healthcare Innovation Fund (2019)

As an innovator in the medtech space, I’m privileged to have gotten the access to CIH’s support so early into my start-up journey. CIH offers a holistic support to both the innovation and the innovator. The implantable medtech space is a tough yet rewarding journey. It takes a village to commercialize a medical implant technology, passing all the quality, regulatory and clinical pathways, without undermining the fund raising part. CIH is here to hand hold and guide the medtech spin-offs at various stages of development. They trusted me and my innovation, way too early into my journey. Their trust and subsequent seed funding has helped me gain the trust of other stakeholders and boost my value. I can’t imagine my entrepreneurial journey without CIH in it. My heart-felt gratitude to CIH and its absolutely amazing people for their inimitable and consistent support. Anyday, CIH is the backbone of my entrepreneurial journey and it’s my pleasure to be a part of their portfolio spin-offs.

Elisa Lim

Will & Well

The CIH community have been supportive by getting Will & Well exposed to the med tech space and exposing us to opportunities with hospitals. Besides, we’re well hosted in a cosy space curated by team CIH. We look forward to future collaborations and opportunities in the space!

Ivan Goh


Getting a medical device from the lab to market can often feel like a long and perilous journey up the mountain. Having a good partner like CIH who is interested in your success, and to provide timely support and insights is invaluable. Thanks team at CIH for your mentors’ guidance, for opening doors for us, and for providing us timely additional resources to forge ahead!

Testimonials from Innovation Commercialisation Program Start-ups

Cailin Ng

Co-founder, HiCura Medical Pte Ltd

We have received a lot of support from the CIH team, from gathering very useful feedback from the team of anaesthesiologists in NUHS to planning out our regulatory strategy moving forward.

Rina and team are very approachable and helpful, and have connected us to good resources. Thank you CIH!

Myongbin Chang

Team Leader, Docfriends Corp

The two months with CIH for ICP Phase 1 has been of great help. This was a great chance for us to check the possibility and opportunity we have in Singapore’s medical settings.

Having the chance to understand the typical medical journey and the relationship between professors and patients was helpful in understanding how our messenger platform would integrate.

Steven Vasilescu

CEO, Microgenesis Ptv Ltd

The Innovators Commercialisation Program (ICP) has introduces Microgenesis to a multitude of clinical experts in reproductive healthcare, enabling us to seek opportunities outside Australia and begin collaborations beyond our reach alone. Through the program we also received invaluable advice on regulatory approval and clinical feedback on our technology.

Alvin He

Vice President and Co-Founder, Ascent Innovation

The CIH team is very professional and provide us a lot of expert opinions regarding our design and commercial route. Also, the fireside chat session is very helpful, and we have a better idea now regarding implementing our work for clinical practice overseas. And we do look forward to exploring further collaboration opportunity with NUHS and CIH in clinical trials.

Margaret Dah

Chief Strategy Officer, JelloX Biotech Inc

NUHS-CIH organizers clearly introduced the purpose of Phase 1 activities with suggested timetable for interactive events including technology feature summary, intended use, regulatory affair assessment, fireside chat, and deep dive discussion, we have thus encountered may experts in regulatory affair, pathologists, oncologists, and business development, and investment network.  KOL’s opinions are well received and appreciated.